• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/15

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

15 Cards in this Set

  • Front
  • Back
Levodopa
MOA
AE
Containdications
MOA: increases DA precursor in CNS

AE: orthostatic hypotension, cardiac stimulation of both a and B receptors, dyskinesias, "on-off syndrome"

Containdications: vit.B6/pyridoxine(increases peripheral conversion to DA), tricyclic antideprssants, (increase orthostatic hypotension), Antipsychotics (are DA antagonists), anticholinergics (slow gastric emptying --> derc abs of L-dopa), MAOI (incr effect of DA --> HTN) [PAAAM]
Carbidopa
MOA
MOA: blocks AADC in periphery, increases Ldopa in CNS

does not cross BBB
Given with Ldopa to reduce side effects
DA agonists
MOA
AE
Containdications
1st LINE!!!!!!

Non-Ergot Derrived: Pramipexole [D2] (NEUROPROTECTIVE) / Ropinerole [D3]

MOA: direct activation of DA-R
Also used for Restless Leg syndrome (RLS)

AE: nausea, dizziness, impulse control disorders, hallucinations
-Less "on-off"
-Less dyskinesias

Ergot Derrived: Bromocriptine
MOA: direct DA-R' activator
Amantadine
MOA
AE
MOA:incr. DA release from good neurons
Also blocks NMDA R's

AE: mild and reversible hallucinations, confusion, nightmares, etc
Anticholinergic Drugs
MOA
AE
Trihexyphenidyl / benztropine

block unopposed cholinergic effects in BG --> decr. tremor

AE:
CNS: Confusion, delirium, somolence, hallucinations
Peripheral: CYCLOPLEGIA, constipation, urinary retention
MAOB Inhibitors
MOA
AE
Selegiline / Rasalgeline (NEUROPROTECTIVE)

MOA: block degradation of DA

AE: nausea, Dizziness
Must keep a low dose
Digoxin
MOA:
AE:
Contraidications
Use for: HF, A-fib, A-flutter, PAT

MOA: [cardiac glycoside] incr. contraction; incr. psym/decr. symp; incr. refractory period at AV node

AE: arrhythmias, agitation/fatigue, yellow-green halo

Contraindications: Amioderone, Beta-Blockers, CCB, Diuretics, Erythromycin, Quinidine, Verapimil, , V-fib, V-Tach, [ABCDEQ-3V]
Streptomycin
MOA
AE
MOA: binds to 30s ribosomal subunit; blocks protein sysnthesis; Bacteriocidal

AE: ototoxicity, vertigo, nephrotoxicity

Given IM only
Rifampin
MOA
AE
Contraindications
MOA: inhibits DNA-dependent RNA synthase; blocks RNA synthesis; Bacteriocidal

AE: rash, fever, flu-like symp. Red/Organge body fluids; INCR. P450

Contraindications: Anticoagulants, anti-fungals, Beta-Blockers, Contraceptives, HIV (PI, NNRTI) [AABC-H]

RECALL: 5 Rs : RNA polymerase, Revs up p450, Resistance, Red-orange, Rash
Isonizide (INH)
MOA
AE
MOA: inhibits synthesis of myocolic acids; bacteriocidal

AE: Hepatotoxicity, Nephrotoxicity, B6 deficiency, DECR. P450

Containdications: Renal Failure, Liver Failure
Pyrazimide
AE
MOA is unknown

AE: hepatotoxicity
Hyperuricemia --> GOUT
Ethambutol
MOA
AE
inhibits Arabinosyl Transferase; Bacteriostatic

AE: Optic Neuritis, Hyperuricemia --> GOUT
Sulfyureas
MOA
AE
Contraindications
Ends in -ride,-mide, -zide

MOA: incr. release of insulin, blocks K+ channel --> depol

these are prodrugs that is converted to the active form in the LIVER, and excreted as an active metabolite in the KIDNEY

AE: HYPOGLYCEMIA

Contraindications: Liver failure, Renal Failure
Repaglinide/ Nateglinide
MOA
MOA: Incr. Insulin Release

MOA is similar but diff from sulfyureas

Short acting, Fast onset
Metformin
MOA
AE
Contraindications
MOA: Decr. gluconeogenesis; incr. glycolysis; decr. glucagon, decr. GI abs of glucose

AE: lactic acidosis (glycolysis), metallic taste, GI effects

Contraindications: Renal Failure, Liver Failure

** does not cause hypoglycemia